# Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

> **NCT00845663** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 98 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Certolizumab pegol
- **DRUG:** Certolizumab pegol

## Key facts

- **NCT ID:** NCT00845663
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2011-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845663, "Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00845663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*